Cargando…

Late Post-Coronavirus Disease 2019 Inflammatory Syndrome: A Case Experience with Tocilizumab

Detalles Bibliográficos
Autores principales:	Tabarsi, Payam, Afzal, Golnaz, Eskandari, Raha, Dastan, Farzaneh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	National Research Institute of Tuberculosis and Lung Disease 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8978043/ https://www.ncbi.nlm.nih.gov/pubmed/35382084

Ejemplares similares

Tocilizumab administration in a refractory case of COVID-19
por: Dastan, Farzaneh, et al.
Publicado: (2020)

Tocilizumab as a promising agent against COVID-19: Issues and challenges
por: Dastan, Farzaneh, et al.
Publicado: (2021)

Thalidomide against Coronavirus Disease 2019 (COVID-19): A Medicine with a Thousand Faces
por: Dastan, Farzaneh, et al.
Publicado: (2020)

A Fourteen-day Experience with Coronavirus Disease 2019 (COVID-19) Induced Acute Respiratory Distress Syndrome (ARDS): An Iranian Treatment Protocol
por: Jamaati, Hamidreza, et al.
Publicado: (2020)

The effects of combination-therapy of tocilizumab and baricitinib on the management of severe COVID-19 cases: a randomized open-label clinical trial
por: Dastan, Farzaneh, et al.
Publicado: (2023)

Use of tocilizumab in multisystem inflammatory syndrome in children associated with severe acute respiratory syndrome coronavirus 2
por: Banday, Aaqib Zaffar, et al.
Publicado: (2021)

Interleukin-6 Antagonist Tocilizumab to Treat Critically Ill Coronavirus Disease 2019 Patients With Cytokine Release Syndrome: A Case Series
por: Yang, Stephen Su, et al.
Publicado: (2021)

Oxygenation Efforts for Iranian COVID-19 ARDS Patients: First 5-Day Crisis Experience Scenario
por: Hashemian, Seyed Mohammadreza, et al.
Publicado: (2020)

Pulmonary tuberculosis and rhinosinus mucormycosis co-infection in a diabetic patient
por: Shabani, Shiva, et al.
Publicado: (2022)

Monitoring neutrophil-to-lymphocyte ratio in patients with coronavirus disease 2019 receiving tocilizumab
por: Hartog, Nicholas L., et al.
Publicado: (2021)

Evaluating the effects of Intravenous Immunoglobulin (IVIg) on the management of severe COVID-19 cases: A randomized controlled trial
por: Tabarsi, Payam, et al.
Publicado: (2021)

Coronavirus disease 2019, Kawasaki disease, and multisystem inflammatory syndrome in children
por: Bassareo, Pier Paolo, et al.
Publicado: (2020)

Epidemiological studies on coronavirus disease 2019 pandemic in India: Too little and too late?
por: Gandhi, P. Aravind, et al.
Publicado: (2020)

Coronavirus disease 2019, multisystem inflammatory syndrome in children, apolipoprotein E4, and race
por: Goldstein, Mark R., et al.
Publicado: (2021)

Study Protocol on Antimicrobial Stewardship in a Tertiary Respiratory Referral Hospital
por: Jamaati, Hamidreza, et al.
Publicado: (2018)

Promising effects of tocilizumab in COVID-19: A non-controlled, prospective clinical trial
por: Dastan, Farzaneh, et al.
Publicado: (2020)

Inflammatory Bowel Disease Patients With Coronavirus Disease 2019: The Picture Is Taking Shape
por: Papa, Alfredo, et al.
Publicado: (2021)

From coronavirus disease 2019 to long coronavirus disease 2019 in vascular pathology
por: Farinetti, Alberto, et al.
Publicado: (2022)

Immunopathogenesis of Pneumonia in COVID-19
por: Alipoor, Shamila D., et al.
Publicado: (2020)

Armarium facilitating angina management post myocardial infarction concomitant with coronavirus disease 2019
por: Cai, Xiao-Qing, et al.
Publicado: (2020)

Tocilizumab in severe COVID-19
por: Lucio Liberato, Nicola, et al.
Publicado: (2020)

The effectiveness of Colchicine as an anti-inflammatory drug in the treatment of coronavirus disease 2019: Meta-analysis
por: Golpour, Monireh, et al.
Publicado: (2021)

Outcomes of acute coronary syndromes in coronavirus disease 2019
por: Cammann, Victoria L., et al.
Publicado: (2020)

Re: Early administration of tocilizumab in hospitalized COVID-19 patients with elevated inflammatory markers; COVIDSTORM
por: Klopfenstein, Timothée, et al.
Publicado: (2022)

2019 Novel coronavirus and awareness
por: Joob, Beuy, et al.
Publicado: (2020)

Coronavirus disease 2019 and pregnancy
por: Rasmussen, Sonja A., et al.
Publicado: (2021)

Coronavirus disease 2019 in pregnancy
por: Tang, Mi, et al.
Publicado: (2021)

Cytomegalovirus Viremia, Pneumonitis, and Tocilizumab Therapy
por: van Duin, David, et al.
Publicado: (2011)

‘Early administration of tocilizumab in hospitalized COVID-19 patients with elevated inflammatory markers; COVIDSTORM’ – Author's reply
por: Broman, Niklas, et al.
Publicado: (2022)

Coronavirus Disease 2019: The Impact of Coronavirus Disease 2019 on the Use of Air Ambulances for International Medical Assistance
por: Duchateau, François-Xavier, et al.
Publicado: (2021)

Stroke in the Time of Coronavirus Disease 2019: Experience of Two University Stroke Centers in Egypt
por: Roushdy, Tamer M., et al.
Publicado: (2020)

Clinical experience with high-flow nasal cannulas for coronavirus disease 2019 patients in Japan
por: Katsuno, Takashi, et al.
Publicado: (2021)

Is There Still a Place for Tocilizumab in Coronavirus Disease 2019?
por: Klopfenstein, Timothée, et al.
Publicado: (2021)

Stress Reduction Strategies in the Coronavirus Pandemic
por: Adibi, Amir, et al.
Publicado: (2020)

Brazilian pulmonology guidelines on Delphi panel for post-coronavirus disease 2019: reflections on persons deprived of liberty
por: Bucar, Sarah Maria Reis, et al.
Publicado: (2023)

Hemoptysis Resolution with Rituximab in Behçet's Disease: A Case Report
por: Jamaati, Hamidreza, et al.
Publicado: (2022)

Mechanisms of Stroke in Coronavirus Disease 2019
por: Montalvan, Victor, et al.
Publicado: (2020)

Vertical transmission of coronavirus disease 2019
por: Martinez-Portilla, Raigam Jafet
Publicado: (2021)

Future for coronavirus disease 2019: India
por: Roy, Manas Pratim
Publicado: (2020)

Coronavirus disease 2019 vaccines in pregnancy
por: Al-Lami, Rasha A.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jqr728jbu99a1lgd28is8iab2e